Why Amarin Stock Was Rocketing Higher on Wednesday
There was unambigously good news about the company's single commercialized medication.
Stay updated with breaking news from Patrick Holt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
There was unambigously good news about the company's single commercialized medication.
Serena: Murder mystery, starring Patrick Holt. Serena airs on Talking Pictures TV at 7:00 AM, Sunday 31 March. Murder mystery, starring Patrick Holt
-- Company Delivers Total Revenues of $75 Million in the Fourth Quarter and $306 Million for the Full-Year 2023 ---- Reaffirms Year-End 2023 Cash Position of $321 Million and Full-Year Positive Cash Flow of $10 Million -- -- Company Reports Fourth Quarter 2023 Total Operating Expense of $50 Million ---- Initiated Shareholder Approval Process to Execute a Share Repurchase Program of up to $50 Million by the End of the Second Quarter 2024 ---- Company to Host Conference Call Today at 8:00 a.m. EDT
Amarin's Q4 2023 financials: Revenues at $74.71 million, beating consensus. US net product revenue is $64.9 million, down Y/Y. CEO Patrick Holt shares operational progress, including European market signs. Amarin initiates a $50 million buyback, on track for $40 million in annual savings.
AMRN earnings call for the period ending December 31, 2023.